A Comparison of Immediate and Extended Release Venlafaxine Following Bariatric Surgery

Trial Profile

A Comparison of Immediate and Extended Release Venlafaxine Following Bariatric Surgery

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Apr 2016

At a glance

  • Drugs Venlafaxine (Primary)
  • Indications Anxiety disorders; Diabetic neuropathies; Generalised anxiety disorder; Major depressive disorder; Panic disorder; Social phobia
  • Focus Pharmacokinetics
  • Most Recent Events

    • 05 Apr 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 11 May 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
    • 19 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top